164 related articles for article (PubMed ID: 30561862)
1. Chemiluminescent Probe for the In Vitro and In Vivo Imaging of Cancers Over-Expressing NQO1.
Son S; Won M; Green O; Hananya N; Sharma A; Jeon Y; Kwak JH; Sessler JL; Shabat D; Kim JS
Angew Chem Int Ed Engl; 2019 Feb; 58(6):1739-1743. PubMed ID: 30561862
[TBL] [Abstract][Full Text] [Related]
2. Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics.
Gong Q; Yang F; Hu J; Li T; Wang P; Li X; Zhang X
Eur J Med Chem; 2021 Nov; 224():113707. PubMed ID: 34303080
[TBL] [Abstract][Full Text] [Related]
3. Characterization of a highly specific NQO1-activated near-infrared fluorescent probe and its application for in vivo tumor imaging.
Punganuru SR; Madala HR; Arutla V; Zhang R; Srivenugopal KS
Sci Rep; 2019 Jun; 9(1):8577. PubMed ID: 31189950
[TBL] [Abstract][Full Text] [Related]
4. Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation.
Bian J; Li X; Xu L; Wang N; Qian X; You Q; Zhang X
Eur J Med Chem; 2017 Feb; 127():828-839. PubMed ID: 27829520
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of NQO1 responsive fluorescence probe and its application in bio-imaging for cancer diagnosis.
Yuan Z; Xu M; Wu T; Zhang X; Shen Y; Ernest U; Gui L; Wang F; He Q; Chen H
Talanta; 2019 Jun; 198():323-329. PubMed ID: 30876568
[TBL] [Abstract][Full Text] [Related]
6. High-contrast NIR fluorescent probes for selective detection of NQO1 in breast cancer.
Liu H; Hu F; Cao Z; Qu Y; Wen H; Wang X; Li W
Spectrochim Acta A Mol Biomol Spectrosc; 2024 Apr; 311():123898. PubMed ID: 38340443
[TBL] [Abstract][Full Text] [Related]
7. A new screening system for NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones: identification of a new aziridinylbenzoquinone, RH1, as a NQO1-directed antitumor agent.
Winski SL; Hargreaves RH; Butler J; Ross D
Clin Cancer Res; 1998 Dec; 4(12):3083-8. PubMed ID: 9865924
[TBL] [Abstract][Full Text] [Related]
8. Developing Push-Pull Hydroxylphenylpolyenylpyridinium Chromophores as Ratiometric Two-Photon Fluorescent Probes for Cellular and Intravital Imaging of Mitochondrial NQO1.
Yang YP; Qi FJ; Qian YP; Bao XZ; Zhang HC; Ma B; Dai F; Zhang SX; Zhou B
Anal Chem; 2021 Feb; 93(4):2385-2393. PubMed ID: 33439630
[TBL] [Abstract][Full Text] [Related]
9. Genetic evidence for NAD(P)H:quinone oxidoreductase 1-catalyzed quinone reduction on passage through the mouse pulmonary circulation.
Lindemer BJ; Bongard RD; Hoffmann R; Baumgardt S; Gonzalez FJ; Merker MP
Am J Physiol Lung Cell Mol Physiol; 2011 May; 300(5):L773-80. PubMed ID: 21296895
[TBL] [Abstract][Full Text] [Related]
10. A bioluminescent probe for NQO1 overexpressing cancer cell imaging
Luo Y; Wang W; Zeng Y; Wang S; Guo X; Hu R; Yang G
Analyst; 2022 Nov; 147(23):5264-5268. PubMed ID: 36330961
[TBL] [Abstract][Full Text] [Related]
11. Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues.
Cheng Z; Valença WO; Dias GG; Scott J; Barth ND; de Moliner F; Souza GBP; Mellanby RJ; Vendrell M; da Silva Júnior EN
Bioorg Med Chem; 2019 Sep; 27(17):3938-3946. PubMed ID: 31327676
[TBL] [Abstract][Full Text] [Related]
12. Profluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1.
Silvers WC; Prasai B; Burk DH; Brown ML; McCarley RL
J Am Chem Soc; 2013 Jan; 135(1):309-14. PubMed ID: 23198810
[TBL] [Abstract][Full Text] [Related]
13. The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins.
Guo W; Reigan P; Siegel D; Zirrolli J; Gustafson D; Ross D
Mol Pharmacol; 2006 Oct; 70(4):1194-203. PubMed ID: 16825487
[TBL] [Abstract][Full Text] [Related]
14. Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1.
Dehn DL; Winski SL; Ross D
Clin Cancer Res; 2004 May; 10(9):3147-55. PubMed ID: 15131056
[TBL] [Abstract][Full Text] [Related]
15. Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative profluorophore.
Hettiarachchi SU; Prasai B; McCarley RL
J Am Chem Soc; 2014 May; 136(21):7575-8. PubMed ID: 24813575
[TBL] [Abstract][Full Text] [Related]
16. C609T polymorphism of NAD(P)H quinone oxidoreductase 1 as a predictive biomarker for response to amrubicin.
Takakuwa O; Oguri T; Ozasa H; Uemura T; Kunii E; Kasai D; Miyazaki M; Maeno K; Sato S
J Thorac Oncol; 2011 Nov; 6(11):1826-32. PubMed ID: 21964527
[TBL] [Abstract][Full Text] [Related]
17. A near-infrared fluorescent probe with two-photon excitation for in situ imaging of NQO1 in human colorectum cancer tissue.
Jiang W; An W; Huang Z; Xu C; Shen Q; Pu C; Zhang S; Wu Q; Li L; Yu C
Talanta; 2024 Jul; 274():126018. PubMed ID: 38593645
[TBL] [Abstract][Full Text] [Related]
18. An improved cell-permeable fluorogenic substrate as the basis for a highly sensitive test for NAD(P)H quinone oxidoreductase 1 (NQO1) in living cells.
Cuff S; Lewis RD; Chinje E; Jaffar M; Knox R; Weeks I
Free Radic Biol Med; 2018 Feb; 116():141-148. PubMed ID: 29325897
[TBL] [Abstract][Full Text] [Related]
19. Role of NAD(P)H:quinone oxidoreductase 1 (DT diaphorase) in protection against quinone toxicity.
Joseph P; Long DJ; Klein-Szanto AJ; Jaiswal AK
Biochem Pharmacol; 2000 Jul; 60(2):207-14. PubMed ID: 10825465
[TBL] [Abstract][Full Text] [Related]
20. A Functional Chemiluminescent Probe for in Vivo Imaging of Natural Killer Cell Activity Against Tumours.
Scott JI; Gutkin S; Green O; Thompson EJ; Kitamura T; Shabat D; Vendrell M
Angew Chem Int Ed Engl; 2021 Mar; 60(11):5699-5703. PubMed ID: 33300671
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
